Henrik Sengeløv

Henrik Sengeløv

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 10 out of 103Page size: 10
Sort by: 1st author
  1. Published

    Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The CSRFENCE score

    Aagaard, T., Reekie, J., Roen, A., Daugaard, G., Specht, Lena, Sengeløv, Henrik, Mocroft, A., Lundgren, Jens & Helleberg, M., 15 Jan 2020, In: International Journal of Cancer. 146, 2, p. 321-328 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

    Aagaard, T., Reekie, J., Jørgensen, M., Roen, A., Daugaard, G., Specht, Lena, Sengeløv, Henrik, Mocroft, A., Lundgren, Jens & Helleberg, M., May 2020, In: Cancer Medicine. 9, 9, p. 3033-3042 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

    Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Akan, H., Yanez San Segundo, L., Pabst, T., Özçelik, T., Klyasova, G., Donnini, I., Wu, D., Gülbas, Z., Zuckerman, T., Botelho de Sousa, A., Beguin, Y., Xhaard, A., Bachy, E., Ljungman, P., de la Camara, R., Rascon, J. & 21 others, Ruiz Camps, I., Vitek, A., Patriarca, F., Cudillo, L., Vrhovac, R., Shaw, P. J., Wolfs, T., O'Brien, T., Avni, B., Silling, G., Al Sabty, F., Graphakos, S., Sankelo, M., Sengeløv, Henrik, Pillai, S., Matthes, S., Melanthiou, F., Iacobelli, S., Styczynski, J., Engelhard, D. & Cesaro, S., 2017, In: Clinical Infectious Diseases. 65, 11, p. 1819-1828

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

    Baron, F., Labopin, M., Ruggeri, A., Cornelissen, J. J., Meijer, E., Sengeløv, Henrik, Niederwieser, D., De Groot, M. R., Schouten, H. C., Milpied, N., Blaise, D., Savani, B. N., Gluckman, E., Mohty, M. & Nagler, A., 15 Jun 2018, In: Clinical Cancer Research. 24, 12, p. 2794-2803 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT

    Baron, F., Ngoya, M., Labopin, M., Cornelissen, J. J., Ganser, A., Forcade, E., Sengeløv, Henrik, Socié, G., Blaise, D., Bornhäuser, M., Valerius, T., Reinhardt, H. C., Kröger, N., Ruggeri, A., Nagler, A. & Mohty, M., 2021, In: Bone Marrow Transplantation. 56, 11, p. 2742-2748 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

    Cahu, X., Labopin, M., Giebel, S., Aljurf, M., Kyrcz-Krzemien, S., Socié, G., Eder, M., Bonifazi, F., Bunjes, D., Vigouroux, S., Michallet, M., Stelljes, M., Zuckerman, T., Finke, J., Passweg, J., Yakoub-Agha, I., Niederwieser, D., Sucak, G., Sengeløv, H., Polge, E. & 4 others, Nagler, A., Esteve, J., Mohty, M. & Acute Leukemia Working Party of EBMT, A. L. W. P. O. E., 2016, In: Bone. 51, p. 351-357 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

    Craddock, C., Labopin, M., Robin, M., Finke, J., Chevallier, P., Yakoub-Agha, I., Bourhis, J. H., Sengeløv, Henrik, Blaise, D., Luft, T., Hallek, M., Kroeger, N., Nagler, A. & Mohty, M., Jul 2016, In: Haematologica. 101, 7, p. 879-83 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection

    Cunha-Bang, C. D., Kirkby, N., Sønderholm, M., Sørensen, S. S., Sengeløv, Henrik, Iversen, M., Rasmussen, A., Gustafsson, Finn, Frederiksen, C. M., Kjaer, J., Lepri, A. C. & Lundgren, Jens, Feb 2013, In: American Journal of Transplantation (Online). 13, 2, p. 458-66 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation

    Ebbesen, M., Enevold, C., Juul, Anders, Heilmann, C., Sengeløv, Henrik & Muller, Klaus, 2020, In: Frontiers in Immunology. 11, 1646.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?

    Ekenberg, C., Lodding, I. P., Wareham, N. E., Sørensen, Søren Schwartz, Sengeløv, Henrik, Gustafsson, Finn, Rasmussen, A., Perch, Michael, Lundgren, Jens & Helleberg, M., 2017, In: European Journal of Clinical Microbiology & Infectious Diseases. 36, 12, p. 2391-2398

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 10801252